Skip to main content
. 2014 Sep 27;14:276. doi: 10.1186/s12888-014-0276-x

Table 1.

Summary of the included studies in the meta-analysis

Authors Year Duration Group1/ Sample Group 2/ Sample Group 3/ Sample Group 4/ Sample Group 5/ Sample
Alvarez E et al. [10] 2011 6 weeks Vortioxetine 5 mg/108 Vortioxetine 10 mg/100 Venlafaxine/113 Placebo/105 ---
Baldwin DS et al. [14] 2012 8-week Vortioxetine 2.5 mg/155 Vortioxetine 5 mg/155 Vortioxetine 10 mg/151 Duloxetine 60 mg/149 Placebo/145
Mahableshwarkar AR et al. [16] 2013 8 weeks Vortioxetine 2.5 mg/146 Vortioxetine 5 mg/153 Duloxetine 60 mg/149 Placebo/149 ---
Katona C et al. [11] 2012 8 weeks Vortioxetine 5 mg/day/154 Duloxetine/147 Placebo/145 --- ---
Jain R et al. [15] 2013 6 wks Vortioxetine 5 mg/300 Placebo/300 --- --- ---
Boulenger JP et al. [12] 2013 8 weeks Vortioxetine 15 mg/151 Vortioxetine 20 mg/151 Duloxetine/147 Placebo/158 ---
Henigsberg N et al. [13] 2012 8 wks Vortioxetine 1 mg/124 Vortioxetine 5 mg/129 Vortioxetine 10 mg/122 Placebo/128 ---